Roche Holding AG
🇨🇭Switzerland
- Country
- 🇨🇭Switzerland
- Ownership
- Public
- Established
- 1896-01-15
- Employees
- 103.6K
- Market Cap
- $270.5B
- Website
- http://www.roche.com
THOR Study: A Study of Continued Herceptin (Trastuzumab) in Combination With Second Line Chemotherapy in Patients With HER2 Positive Metastatic Breast Cancer.
- First Posted Date
- 2007-03-16
- Last Posted Date
- 2014-10-24
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 58
- Registration Number
- NCT00448279
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Endocrine Tumors of the Gastrointestinal Tract.
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-03-16
- Last Posted Date
- 2015-01-22
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 83
- Registration Number
- NCT00448136
A Study of Herceptin (Trastuzumab) in Combination With 2nd-Line Chemotherapy in Patients With HER2 Positive Metastatic Breast Cancer.
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-03-08
- Last Posted Date
- 2016-06-21
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 114
- Registration Number
- NCT00444587
A Study Comparing Mircera and Epoetin Beta for the Treatment of Anemia in Dialysis Patients With Chronic Kidney Disease.
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-03-02
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 265
- Registration Number
- NCT00442793
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
Phase 3
Terminated
- Conditions
- Interventions
- First Posted Date
- 2007-03-02
- Last Posted Date
- 2016-08-17
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 80
- Registration Number
- NCT00442416
SOFIA-LTT Study: A Study of Intermittent Long Term Treatment With PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With HBeAg Negative Chronic Hepatitis B (CHB).
- First Posted Date
- 2007-03-02
- Last Posted Date
- 2017-04-06
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 21
- Registration Number
- NCT00442572
- Locations
- 🇧🇬
Mhat St. Ivan Rilski; Clinic of Gastroenterology, Sofia, Bulgaria
A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.
- First Posted Date
- 2007-03-02
- Last Posted Date
- 2011-12-19
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 228
- Registration Number
- NCT00442702
A Study of NeoRecormon (Epoetin Beta) in Patients With Renal Anemia.
Phase 4
Terminated
- Conditions
- First Posted Date
- 2007-02-26
- Last Posted Date
- 2007-12-20
- Lead Sponsor
- Hoffmann-La Roche
- Registration Number
- NCT00440063
A Study of Xeloda (Capecitabine) in Combination With XELOX (Oxaliplatin) in Patients With Metastatic Nasopharyngeal Cancer.
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-02-23
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 25
- Registration Number
- NCT00439426
A Study of NeoRecormon in Patients With Chronic Kidney Disease.
- First Posted Date
- 2007-02-21
- Last Posted Date
- 2009-05-14
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 90
- Registration Number
- NCT00437723
© Copyright 2024. All Rights Reserved by MedPath